Literature DB >> 6084612

Investigation of the antigenic structure of rabies virus glycoprotein by monoclonal antibodies.

M Lafon, J Ideler, W H Wunner.   

Abstract

Comparative antigenic analysis of glycoprotein variants of ERA and CVS-11 strains of rabies virus by monoclonal antibodies has permitted the delineation of three antigenic sites on the glycoprotein common to both strains. Two additional antigenic sites have been delineated on the ERA strain virus glycoprotein. The topologic relationship of these antigenic sites has been investigated.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6084612

Source DB:  PubMed          Journal:  Dev Biol Stand        ISSN： 0301-5149


  10 in total

1.  Structural and immunological characterization of a linear virus-neutralizing epitope of the rabies virus glycoprotein and its possible use in a synthetic vaccine.

Authors:  B Dietzschold; M Gore; D Marchadier; H S Niu; H M Bunschoten; L Otvos; W H Wunner; H C Ertl; A D Osterhaus; H Koprowski
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

2.  Antigenicity of rabies virus glycoprotein.

Authors:  A Benmansour; H Leblois; P Coulon; C Tuffereau; Y Gaudin; A Flamand; F Lafay
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

3.  A unique substitution at position 333 on the glycoprotein of rabies virus street strains isolated from non-hematophagous bats in Brazil.

Authors:  G Sato; Y Kobayashi; N Motizuki; S Hirano; T Itou; E M S Cunha; F H Ito; T Sakai
Journal:  Virus Genes       Date:  2008-10-22       Impact factor: 2.332

4.  Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants.

Authors:  Alexander B H Bakker; Wilfred E Marissen; R Arjen Kramer; Amy B Rice; William C Weldon; Michael Niezgoda; Cathleen A Hanlon; Sandra Thijsse; Harold H J Backus; John de Kruif; Bernhard Dietzschold; Charles E Rupprecht; Jaap Goudsmit
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

5.  Studies on the antigenicity and nucleotide sequence of the rabies virus Nishigahara strain, a current seed strain used for dog vaccine production in Japan.

Authors:  S Sakamoto; T Ide; H Nakatake; S Tokiyoshi; M Yamamoto; A Kawai; J S Smith
Journal:  Virus Genes       Date:  1994-01       Impact factor: 2.332

6.  Biological characterization of human monoclonal antibodies to rabies virus.

Authors:  B Dietzschold; M Gore; P Casali; Y Ueki; C E Rupprecht; A L Notkins; H Koprowski
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

7.  Antigenic and molecular characterization of bat rabies virus in Europe.

Authors:  H Bourhy; B Kissi; M Lafon; D Sacramento; N Tordo
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

8.  Characterization of rabies glycoprotein expressed in yeast.

Authors:  S R Klepfer; C Debouck; J Uffelman; P Jacobs; A Bollen; E V Jones
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

9.  Mokola virus glycoprotein and chimeric proteins can replace rabies virus glycoprotein in the rescue of infectious defective rabies virus particles.

Authors:  T Mebatsion; M J Schnell; K K Conzelmann
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

10.  The adaptation of a CTN-1 rabies virus strain to high-titered growth in chick embryo cells for vaccine development.

Authors:  Caiping Guo; Chunhua Wang; Shan Luo; Shimao Zhu; Hui Li; Yongdi Liu; Lanzhen Zhou; Pei Zhang; Xin Zhang; Yujiang Ding; Weirong Huang; Kaiyong Wu; Yanpeng Zhang; Weihua Rong; Hua Tian
Journal:  Virol J       Date:  2014-05-12       Impact factor: 4.099
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.